Therapeutic Leadership Across Multiple Indications
As a physician-led, therapeutically focused global CRO, Medpace offers medical
leadership in GI, as well as other areas that may cross over into GI studies
including Infectious Disease, Metabolic/Diabetes, and Oncology. Our team
approach provides sponsors with valuable insights from highly
experienced medical doctors into studies that touch on multiple indications.
In addition, Medpace employs a seasoned team of CTMs, CRAs, data managers,
statisticians, safety managers, medical writers, and regulatory managers who are
focused on serving sponsors in all of your clinical development needs.
Gastrointestinal Drug Development Expertise
- Inflammatory Bowel Disease including:
- Ulcerative Colitis
- Crohn's Disease
- Functional GI Disorders including:
- Chronic Idiopathic Constipation (also drug-induced constipation)
- Irritable Bowel Syndrome
- Postprandial Distress and Gastroparesis (also GERD)
- Liver Disease including:
- Viral Hepatitis
- Nonalcoholic steatohepatitis (NASH)
Endoscopy has become a standard outcome measure in many GI indications
including IBD. The concept of mucosal healing and deep remission in Crohn’s
Disease and Ulcerative Colitis has gained momentum with regulators and
prescribers. Centralized imaging allows for standardization of patient inclusion
and outcome assessment.
Imaging Core Lab, a wholly owned subsidiary of Medpace,
provides holistic central imaging service including site assessment,
qualification and training, recording equipment provisioning, image processing
(blinding and quality control) and expert evaluation.
Full-service Central Lab for GI Studies
Medpace Reference Labs (MRL) provides global central laboratory services through
four wholly owned labs located in Belgium, China, India and the USA. Unlike
other global central labs that are grown through acquistion, MRL labs were
custom built and offer identical testing platforms, reagents, calibration and QC
to ensure identical results globally. As a full service central lab, MRL can
help design and execute your protocol testing needs with a strong selection of
inflammatory biomarkers and cytokines.
Recruitment and Global Site Relationships
Medpace has a strong record for study recruitment. This is a direct result of our full-service approach where Medpace’s medical
and operational teams work collaboratively on site feasibility and study design. This team approach, plus strong relationships with
key opinion leaders and investigative sites, drives recruitment success.
Medpace is recognized for its strong site relationships around the world. In both 2011 and 2012, Medpace was recognized by a
global community of clinical research sites as “the most desirable to work with as a clinical research study partner.” Our strong
site relationships contribute to an 85% repeat business metric for Medpace.(Read more about the Site Solutions Summit Eagle Award.)
Our strong site relationships contribute to an 85% repeat business metric.
>> Click here to learn more
about Medpace's capabilities and therapeutic expertise in gastrointestinal diseases and disorders.